ECSP003755A - COMBINATION CHEMOTHERAPY - Google Patents

COMBINATION CHEMOTHERAPY

Info

Publication number
ECSP003755A
ECSP003755A ECSP003755A ECSP003755A EC SP003755 A ECSP003755 A EC SP003755A EC SP003755 A ECSP003755 A EC SP003755A EC SP003755 A ECSP003755 A EC SP003755A
Authority
EC
Ecuador
Prior art keywords
combination chemotherapy
combination
chemotherapy
acetyldinaline
carboplatin
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Wayne Daniel Klohs
Ronald Lynn Merriman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003755 priority Critical patent/ECSP003755A/en
Publication of ECSP003755A publication Critical patent/ECSP003755A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La acetildinalina en combinación con paclitaxel y/o carboplatina es sinergistica para tratar el cáncer.Acetyldinaline in combination with paclitaxel and / or carboplatin is synergistic to treat cancer.

ECSP003755 2000-11-09 2000-11-09 COMBINATION CHEMOTHERAPY ECSP003755A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003755 ECSP003755A (en) 2000-11-09 2000-11-09 COMBINATION CHEMOTHERAPY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003755 ECSP003755A (en) 2000-11-09 2000-11-09 COMBINATION CHEMOTHERAPY

Publications (1)

Publication Number Publication Date
ECSP003755A true ECSP003755A (en) 2001-03-22

Family

ID=42041328

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003755 ECSP003755A (en) 2000-11-09 2000-11-09 COMBINATION CHEMOTHERAPY

Country Status (1)

Country Link
EC (1) ECSP003755A (en)

Similar Documents

Publication Publication Date Title
AR028296A1 (en) SYNERGISTIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
UY28213A1 (en) NEW CYANOPIRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS.
NO20080442L (en) Phosphoramidate alkylator promoter
MXPA05012421A (en) Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents.
DE60106954D1 (en) Resorcinol DERIVATIVES
HRPK20041072B3 (en) DOCETAXEL / DOXORUBICIN / CYCLOPHOSPHAMID APPLICATION TO THE ADjuVANT THERAPY OF BREAST AND OVARIAN CARCINOMA
AR048819A1 (en) SYNERGIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
PA8506201A1 (en) COMBINATION CHEMOTHERAPY (COMBINATION CHEMOTHERAPY)
EA200200808A1 (en) MODIFIED CYTOKINES INTENDED FOR USE IN CANCER TREATMENT
CL2007001514A1 (en) Compounds derived from triazine or diazine substituted by chromane or isochroman, hsp90 inhibitors; pharmaceutical composition comprising; and its use in the treatment of cancer.
BR0114430A (en) Processes for cancer cell death induction and tumor regression
ATE407937T1 (en) RUTHENIUM COMPLEXES WITH ANTI-CANCER EFFECT
ATE399558T1 (en) ANTI-TUMORAL FORMULATIONS CONTAINING DEFIBROTIDE ALONE OR IN COMBINATION WITH OTHER ANTITUMORAL AGENTS
ECSP003755A (en) COMBINATION CHEMOTHERAPY
TR200302193T4 (en) Combination chemotherapy.
DOP2000000092A (en) COMBINATION CHEMOTHERAPY
DE60134740D1 (en) COMPOSITION FOR POTENTIATING CANCER CHEMOTHERAPEUTIC
MXPA04000418A (en) Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines.
ECSP982458A (en) ORAL APPLICATION OF (+) - O- DEMETILTRAMADOL AS AN ANALGESIC
UY29136A1 (en) USE OF EPOTILONES IN THE TREATMENT OF OSEA METASTASIS
DOP2003000674A (en) THERAPEUTIC COMBINATIONS OF ERB B QUINASA INHIBITORS AND ANTINEOOLASIC THERAPIES
CO5280204A1 (en) USE OF GLUTAMINE FOR THE PREVENTION OF LATE DIARRHEA INDUCED BY IRINOTECAN
CL2004000045A1 (en) HETEROAROMATIC COMPOUNDS DERIVED FROM PIPERAZINA, PHARMACEUTICAL COMPOSITION, USEFUL TO TREAT AN ILLNESS LIKE CANCER.
UY27923A1 (en) THERAPEUTIC COMBINATIONS OF ERB B KIN INHIBITORS AND ANTHINEOPLASTIC THERAPIES
AU300157S (en) Underwear